Matinas BioPharma (MTNB) Q2 2024 Earnings
MTNB·Reported August 14, 2024·After market close
Diluted EPS came in at $-1.00, missed the $-0.83 consensus by $0.17.
Diluted EPS
$-1.00missed by $0.17
Consensus: $-0.83
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Matinas BioPharma's Q2 2024 earnings report.
Matinas BioPharma (MTNB) reported Q2 2024 earnings on August 14, 2024 after market close.
Matinas BioPharma reported diluted EPS of $-1.00 for Q2 2024.
EPS missed the consensus estimate of $-0.83 by $0.17.
You can read the 10-Q periodic report (0001493152-24-032144) directly on SEC EDGAR. The filing index links above go to sec.gov.